BIOEQUIVALENCE
Clinical trials for BIOEQUIVALENCE explained in plain language.
Never miss a new study
Get alerted when new BIOEQUIVALENCE trials appear
Sign up with your email to follow new studies for BIOEQUIVALENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New advil mini tablet put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a new, smaller Advil Mini tablet (200 mg ibuprofen) works just like the regular Advil tablet in healthy adults. It also looked at how taking the Mini tablet with food changes its absorption. Fifty healthy volunteers took both versions and had blood samples t…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: HALEON • Aim: Knowledge-focused
Last updated May 26, 2026 11:09 UTC
-
Generic vs. brand: are these seizure meds equal?
Knowledge-focused CompletedThis study tested whether a new granule form of levetiracetam works the same as the standard tablet in 20 healthy adults. Participants took a single dose of each version under fasting conditions. The goal was to check bioequivalence, meaning the body absorbs and processes both fo…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: Desitin Arzneimittel GmbH • Aim: Knowledge-focused
Last updated May 26, 2026 10:58 UTC
-
New liquid version of PKU drug tested for equivalence
Knowledge-focused CompletedThis study tested whether a new liquid form of the drug sapropterin works the same as the current powder form in healthy adults. 42 participants received a single dose of each version under fed conditions, and researchers measured drug levels in the blood. The goal was to confirm…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: APR Applied Pharma Research s.a. • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC
-
Healthy volunteers test new tablet version of KBP 5074
Knowledge-focused CompletedThis study tested a new tablet form of the experimental drug KBP 5074 against the current capsule form in 20 healthy adults aged 18 to 45. Researchers measured how the drug moves through the body and checked for side effects. The results will help decide which dose to use in futu…
Matched conditions: BIOEQUIVALENCE
Phase: PHASE1 • Sponsor: KBP Biosciences • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC